Xuanxuan Nian

Wuhan, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications

Age-dependent immune landscapes affect influenza vaccine effectiveness and guide precision strategies.

Age-dependent immune landscapes affect influenza vaccine effectiveness and guide precision strategies.

Journal: Frontiers in immunology
Published: June 25, 2026

Evaluation of Safety and Immunogenicity of High-Dose Quadrivalent Seasonal Influenza Split Vaccine: A Preclinical Study.

Evaluation of Safety and Immunogenicity of High-Dose Quadrivalent Seasonal Influenza Split Vaccine: A Preclinical Study.

Journal: Vaccines
Published: April 17, 2026

Tumorigenicity decrease in Bcl-xL deficient MDCK cells ensuring the safety for influenza vaccine production.

Tumorigenicity decrease in Bcl-xL deficient MDCK cells ensuring the safety for influenza vaccine production.

Journal: PloS one
Published: September 18, 2024

Production, Passaging Stability, and Histological Analysis of Madin-Darby Canine Kidney Cells Cultured in a Low-Serum Medium.

Production, Passaging Stability, and Histological Analysis of Madin-Darby Canine Kidney Cells Cultured in a Low-Serum Medium.

Journal: Vaccines
Published: July 04, 2024

Molecular epidemiology and vaccine compatibility analysis of seasonal influenza A viruses in the context of COVID-19 epidemic in Wuhan, China.

Molecular epidemiology and vaccine compatibility analysis of seasonal influenza A viruses in the context of COVID-19 epidemic in Wuhan, China.

Journal: Journal of medical virology
Published: March 21, 2024

Immunosuppressants exert antiviral effects against influenza A(H1N1)pdm09 virus via inhibition of nucleic acid synthesis, mRNA splicing, and protein stability.

Immunosuppressants exert antiviral effects against influenza A(H1N1)pdm09 virus via inhibition of nucleic acid synthesis, mRNA splicing, and protein stability.

Journal: Virulence
Published: January 03, 2024

Enhanced Downstream Processing for a Cell-Based Avian Influenza (H5N1) Vaccine.

Enhanced Downstream Processing for a Cell-Based Avian Influenza (H5N1) Vaccine.

Journal: Vaccines
Published: November 24, 2023

Human monoclonal antibody F61 nasal spray effectively protected high-risk populations from SARS-CoV-2 variants during the COVID-19 pandemic from late 2022 to early 2023 in China.

Human monoclonal antibody F61 nasal spray effectively protected high-risk populations from SARS-CoV-2 variants during the COVID-19 pandemic from late 2022 to early 2023 in China.

Journal: Emerging microbes & infections
Published: November 16, 2023

Correction: Nian et al. Coping Strategies for Pertussis Resurgence. Vaccines 2023, 11, 889.

Correction: Nian et al. Coping Strategies for Pertussis Resurgence. Vaccines 2023, 11, 889.

Journal: Vaccines
Published: November 08, 2023

Safety and immunogenicity of rabies vaccine (PVRV-WIBP) in healthy Chinese aged 10-50 years old: Randomized, blinded, parallel controlled phase III clinical study.

Safety and immunogenicity of rabies vaccine (PVRV-WIBP) in healthy Chinese aged 10-50 years old: Randomized, blinded, parallel controlled phase III clinical study.

Journal: Human vaccines & immunotherapeutics
Published: May 30, 2023

Suspended cell lines for inactivated virus vaccine production.

Suspended cell lines for inactivated virus vaccine production.

Journal: Expert review of vaccines
Published: May 18, 2023

Coping Strategies for Pertussis Resurgence.

Coping Strategies for Pertussis Resurgence.

Journal: Vaccines
Published: March 15, 2023
Showing 1-12 of 27

Last Updated: 09/26/2026